Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
Department of Cardiac Surgery, Inselspital, University of Bern, Bern, Switzerland.
JACC Cardiovasc Interv. 2024 Oct 28;17(20):2353-2363. doi: 10.1016/j.jcin.2024.07.009. Epub 2024 Oct 9.
Vascular complications remain a major concern in transfemoral transcatheter aortic valve replacement (TAVR). The Hostile score has been proposed to stratify risk in TAVR patients with peripheral artery disease.
The authors aimed to assess the validity of the Hostile score in predicting iliofemoral vascular complications after TAVR.
In a prospective TAVR registry, we validated the Hostile score for the prediction of puncture and non-puncture site vascular complications. This scoring system integrates the extent (number of lesions, lesion length, and minimum lumen diameter) and complexity (tortuosity, calcification, and the presence of obstruction) of iliofemoral atherosclerosis.
Of 2,023 patients who underwent transfemoral TAVR with contemporary devices between March 2014 and June 2022, 106 (5.2%) patients experienced puncture site vascular complications and 28 (1.4%) patients experienced non-puncture site vascular complications. The Hostile score was higher in patients with vascular complications than those without complications (1.00 [Q1-Q3: 0-5.00] vs 1.00 [Q1-Q3: 0-4.00]; P < .001). A higher body mass index (OR: 1.23; 95% CI: 1.04-1.50) and the use of Prostar (OR: 6.03; 95% CI: 2.23-16.30) or MANTA (OR: 6.18; 95% CI: 2.67-14.27) compared with ProGlide were independent predictors of puncture site vascular complications, whereas a higher Hostile score (OR: 1.91; 95% CI: 1.55-2.35) and female sex (OR: 2.69; 95% CI: 1.12-6.42) were independent predictors of non-puncture site vascular complications. The area under the receiver-operating characteristic curves for the prediction of puncture site and non-puncture site vascular complications were 0.554 and 0.829, respectively.
The Hostile score proved useful in predicting non-puncture site vascular complications after TAVR. (SwissTAVI Registry; NCT01368250).
在经股动脉经导管主动脉瓣置换术(TAVR)中,血管并发症仍然是一个主要关注点。Hostile 评分被提出用于分层经股动脉 TAVR 患者的外周动脉疾病风险。
作者旨在评估 Hostile 评分在预测 TAVR 后髂股血管并发症方面的有效性。
在一项前瞻性 TAVR 注册研究中,我们验证了 Hostile 评分预测穿刺部位和非穿刺部位血管并发症的能力。该评分系统综合了髂股动脉粥样硬化的程度(病变数量、病变长度和最小管腔直径)和复杂性(迂曲、钙化和梗阻的存在)。
在 2014 年 3 月至 2022 年 6 月期间,接受经股动脉 TAVR 治疗的 2023 名患者中,有 106 名(5.2%)患者出现穿刺部位血管并发症,28 名(1.4%)患者出现非穿刺部位血管并发症。有血管并发症的患者的 Hostile 评分高于无并发症的患者(1.00[Q1-Q3:0-5.00] vs 1.00[Q1-Q3:0-4.00];P<.001)。更高的体重指数(OR:1.23;95%CI:1.04-1.50)和使用 Prostar(OR:6.03;95%CI:2.23-16.30)或 MANTA(OR:6.18;95%CI:2.67-14.27)而非 ProGlide 是穿刺部位血管并发症的独立预测因素,而更高的 Hostile 评分(OR:1.91;95%CI:1.55-2.35)和女性(OR:2.69;95%CI:1.12-6.42)是预测非穿刺部位血管并发症的独立预测因素。预测穿刺部位和非穿刺部位血管并发症的受试者工作特征曲线下面积分别为 0.554 和 0.829。
Hostile 评分在预测 TAVR 后非穿刺部位血管并发症方面是有用的。(瑞士 TAVI 注册研究;NCT01368250)。